Search RKDA
Arcadia Biosciences, Inc.
Nasdaq · CIK 1469443
Last close0.29
Daily change+0.00 (1.41%)
10 Years gain-99.98%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
RKDA · STANDARD
SIC 1311 · Crude Petroleum & Natural Gas · Fiscal year end 1231
Fundamental
52.8Momentum
0.0Acceleration
0.0Confidence
83.0Annual Revenue12
Quarterly Revenue44
Annual CFO9
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth4.2 / 25
Quality17.5 / 25
Capital Efficiency10.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics3.5 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 26.1468 percentage points.
Heavy share dilution · HIGHDiluted share count increased 119.0418%.
ROIC declining · MEDIUMROIC declined by 179.4558 percentage points.
Key Metrics
Revenue Growth TTM0.8%OK
Revenue CAGR 3Y-13.16%OK
Gross Margin39.25%OK
Operating Margin-55.25%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-210.19%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y119.04%OK
SBC / Revenue3.17%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $4.86M | $1.76M | -$2.50M | n/a | n/a | 36.23% | -51.46% | n/a | -217.39% | 1.37M |
| 2025 FY Dec 31, 2024 | $5.05M | $2.08M | -$3.65M | -$9.63M | -$9.64M | 41.27% | -72.31% | -191.14% | -181.25% | 1.36M |
| 2024 FY Dec 31, 2023 | $4.45M | $2.28M | -$6.10M | -$15.29M | -$15.30M | 51.19% | -137% | -343.49% | -607.13% | 1.24M |
| 2023 FY Dec 31, 2022 | $7.42M | $1.32M | -$14.01M | -$13.98M | -$14.05M | 17.75% | -188.82% | -189.39% | -791.24% | 599,389 |
| 2022 FY Dec 31, 2021 | $6.78M | -$1.93M | -$35.53M | -$25.87M | -$26.88M | -28.44% | -523.98% | -396.39% | -727.84% | 532,016 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $5.30M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-349205, 0001193125-25-272375 |
| Revenue Growth TTM | 0.8% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-349205, 0001193125-25-272375 |
| Revenue CAGR 3Y | -13.16% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-126238 |
| Revenue CAGR 5Y | -9.57% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-126238 |
| Gross Profit CAGR 3Y | 10.15% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-126238 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-349205, 0001193125-25-272375 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 39.25% | Gross Profit / Revenue | OK | 0001193125-26-349205, 0001193125-25-272375 |
| Operating Margin | -55.25% | Operating Income / Revenue | OK | 0001193125-26-349205, 0001193125-25-272375 |
| ROIC | -210.19% | NOPAT / Average Invested Capital | OK | 0001193125-26-349205, 0001193125-25-272375 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-349205 |
| Current Ratio | 3.49x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 3.17% | SBC / Revenue | OK | 0001193125-26-349205, 0001193125-25-272375 |
| Revenue per Diluted Share | $1.77 | Revenue / Diluted Shares | OK | 0001193125-26-349205, 0001193125-25-272375 |